“Investigator global assessment (IGA) of Acne Vulgaris and IGA Success among patients with moderate to severe non-nodular Acne Vulgaris (AV) administered sarecycline in community practices across the U.S: PROSES study analysis by gender and age” (2023) SKIN The Journal of Cutaneous Medicine, 7(2), p. s156. doi:10.25251/skin.7.supp.156.